- -

miRNA detection methods and clinical implications in lung cancer

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

miRNA detection methods and clinical implications in lung cancer

Mostrar el registro sencillo del ítem

Ficheros en el ítem

Thumbnail
Nombre: Uso, Jantus, Sirera, ...
Tamaño: 431.0Kb
Formato: PDF
Descripción: Versión del Autor.
Abrir
[Cerrado]
Nombre: Sirera;Jantus-Lewintre ...
Tamaño: 1.817Mb
Formato: PDF
Descripción: Versión editorial
Solicitar una copia al autor
dc.contributor.author Usó, Marta es_ES
dc.contributor.author Jantus Lewintre, Eloisa es_ES
dc.contributor.author Sirera Pérez, Rafael es_ES
dc.contributor.author Bremnes, Roy M. es_ES
dc.contributor.author Camps, Carlos es_ES
dc.date.accessioned 2017-03-22T07:49:13Z
dc.date.available 2017-03-22T07:49:13Z
dc.date.issued 2014
dc.identifier.issn 1479-6694
dc.identifier.uri http://hdl.handle.net/10251/78936
dc.description.abstract [EN] Lung cancer is the leading cause of cancer death worldwide. Therefore, advances in the diagnosis and treatment of the disease are urgently needed. miRNAs are a family of small, noncoding RNAs that regulate gene expression at the transcriptional level. miRNAs have been reported to be deregulated and to play a critical role in different types of cancer, including lung cancer. Thus, miRNA profiling in lung cancer patients has become the core of several investigations. To this end, the development of a multitude of platforms for miRNA profiling analysis has been essential. This article focuses on the different technologies available for assessing miRNAs and the most important results obtained to date in lung cancer. es_ES
dc.description.sponsorship This study was partially supported by a grant from the Ministerio de Ciencia e Inovacion de Espana (TRA09-0132), Beca Roche en Onco-Hematologia 2009 and Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
dc.language Inglés es_ES
dc.publisher Future Medicine es_ES
dc.relation.ispartof Future Oncology es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject Biomarker es_ES
dc.subject Diagnosis es_ES
dc.subject Lung cancer es_ES
dc.subject miRNA es_ES
dc.subject miRNA profiling es_ES
dc.subject Prognosis es_ES
dc.subject.classification MICROBIOLOGIA es_ES
dc.title miRNA detection methods and clinical implications in lung cancer es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.2217/FON.14.93
dc.relation.projectID info:eu-repo/grantAgreement/MICINN//TRA2009_0132/ES/Micro ARNs con expresión diferencial en cáncer de pulmón no microcítico: Control sobre la angiogénesis/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/MINECO//RD12%2F0036%2F0025/ES/Cáncer/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Biotecnología - Departament de Biotecnologia es_ES
dc.contributor.affiliation Universitat Politècnica de València. Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural - Escola Tècnica Superior d'Enginyeria Agronòmica i del Medi Natural es_ES
dc.description.bibliographicCitation Usó, M.; Jantus Lewintre, E.; Sirera Pérez, R.; Bremnes, RM.; Camps, C. (2014). miRNA detection methods and clinical implications in lung cancer. Future Oncology. 10(14):2279-2292. https://doi.org/10.2217/FON.14.93 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.2217/FON.14.93
dc.description.upvformatpinicio 2279 es_ES
dc.description.upvformatpfin 2292 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 10 es_ES
dc.description.issue 14 es_ES
dc.relation.senia 303990 es_ES
dc.identifier.eissn 1744-8301
dc.identifier.pmid 25471039
dc.contributor.funder Ministerio de Ciencia e Innovación
dc.contributor.funder Red Temática de Investigación Cooperativa en Cáncer
dc.contributor.funder Ministerio de Economía y Competitividad es_ES
dc.description.references Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61(2), 69-90. doi:10.3322/caac.20107 es_ES
dc.description.references Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008). Lung Cancer. New England Journal of Medicine, 359(13), 1367-1380. doi:10.1056/nejmra0802714 es_ES
dc.description.references Ferlay, J., Parkin, D. M., & Steliarova-Foucher, E. (2010). Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer, 46(4), 765-781. doi:10.1016/j.ejca.2009.12.014 es_ES
dc.description.references Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., … Sobin, L. (2007). The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. Journal of Thoracic Oncology, 2(8), 706-714. doi:10.1097/jto.0b013e31812f3c1a es_ES
dc.description.references Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75(5), 843-854. doi:10.1016/0092-8674(93)90529-y es_ES
dc.description.references Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nature Cell Biology, 11(3), 228-234. doi:10.1038/ncb0309-228 es_ES
dc.description.references Lai, E. C. (2002). Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nature Genetics, 30(4), 363-364. doi:10.1038/ng865 es_ES
dc.description.references Stark, A., Brennecke, J., Bushati, N., Russell, R. B., & Cohen, S. M. (2005). Animal MicroRNAs Confer Robustness to Gene Expression and Have a Significant Impact on 3′UTR Evolution. Cell, 123(6), 1133-1146. doi:10.1016/j.cell.2005.11.023 es_ES
dc.description.references Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007). microRNAs as oncogenes and tumor suppressors. Developmental Biology, 302(1), 1-12. doi:10.1016/j.ydbio.2006.08.028 es_ES
dc.description.references Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., … Croce, C. M. (2002). Nonlinear partial differential equations and applications: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences, 99(24), 15524-15529. doi:10.1073/pnas.242606799 es_ES
dc.description.references Landi, M. T., Zhao, Y., Rotunno, M., Koshiol, J., Liu, H., Bergen, A. W., … Wang, E. (2010). MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer. Clinical Cancer Research, 16(2), 430-441. doi:10.1158/1078-0432.ccr-09-1736 es_ES
dc.description.references Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., … Takahashi, T. (2004). Reduced Expression of thelet-7MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival. Cancer Research, 64(11), 3753-3756. doi:10.1158/0008-5472.can-04-0637 es_ES
dc.description.references Garofalo, M., Di Leva, G., Romano, G., Nuovo, G., Suh, S.-S., Ngankeu, A., … Croce, C. M. (2009). miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. Cancer Cell, 16(6), 498-509. doi:10.1016/j.ccr.2009.10.014 es_ES
dc.description.references Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Diaz, T., Gel, B., … Monzo, M. (2009). miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis, 30(11), 1903-1909. doi:10.1093/carcin/bgp219 es_ES
dc.description.references Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., … Golub, T. R. (2005). MicroRNA expression profiles classify human cancers. Nature, 435(7043), 834-838. doi:10.1038/nature03702 es_ES
dc.description.references Xi, Y., Nakajima, G., Gavin, E., Morris, C. G., Kudo, K., Hayashi, K., & Ju, J. (2007). Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA, 13(10), 1668-1674. doi:10.1261/rna.642907 es_ES
dc.description.references Shen, J., & Jiang, F. (2012). Applications of microRNAs in the diagnosis and prognosis of lung cancer. Expert Opinion on Medical Diagnostics, 6(3), 197-207. doi:10.1517/17530059.2012.672970 es_ES
dc.description.references Doleshal, M., Magotra, A. A., Choudhury, B., Cannon, B. D., Labourier, E., & Szafranska, A. E. (2008). Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics, 10(3), 203-211. doi:10.2353/jmoldx.2008.070153 es_ES
dc.description.references Taylor, D. D., & Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic Oncology, 110(1), 13-21. doi:10.1016/j.ygyno.2008.04.033 es_ES
dc.description.references Ibberson, D., Benes, V., Muckenthaler, M. U., & Castoldi, M. (2009). RNA degradation compromises the reliability of microRNA expression profiling. BMC Biotechnology, 9(1), 102. doi:10.1186/1472-6750-9-102 es_ES
dc.description.references Yin, J. Q., Zhao, R. C., & Morris, K. V. (2008). Profiling microRNA expression with microarrays. Trends in Biotechnology, 26(2), 70-76. doi:10.1016/j.tibtech.2007.11.007 es_ES
dc.description.references Beuvink, I., Kolb, F. A., Budach, W., Garnier, A., Lange, J., Natt, F., … Weiler, J. (2007). A novel microarray approach reveals new tissue-specific signatures of known and predicted mammalian microRNAs. Nucleic Acids Research, 35(7), e52. doi:10.1093/nar/gkl1118 es_ES
dc.description.references Raponi, M., Dossey, L., Jatkoe, T., Wu, X., Chen, G., Fan, H., & Beer, D. G. (2009). MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer. Cancer Research, 69(14), 5776-5783. doi:10.1158/0008-5472.can-09-0587 es_ES
dc.description.references Benes, V., & Castoldi, M. (2010). Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods, 50(4), 244-249. doi:10.1016/j.ymeth.2010.01.026 es_ES
dc.description.references Dijkstra, J. R., Mekenkamp, L. J. M., Teerenstra, S., De Krijger, I., & Nagtegaal, I. D. (2012). MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls. Journal of Cellular and Molecular Medicine, 16(4), 683-690. doi:10.1111/j.1582-4934.2011.01467.x es_ES
dc.description.references Chen, C. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 33(20), e179-e179. doi:10.1093/nar/gni178 es_ES
dc.description.references Lao, K., Xu, N. L., Yeung, V., Chen, C., Livak, K. J., & Straus, N. A. (2006). Multiplexing RT-PCR for the detection of multiple miRNA species in small samples. Biochemical and Biophysical Research Communications, 343(1), 85-89. doi:10.1016/j.bbrc.2006.02.106 es_ES
dc.description.references Mestdagh, P., Feys, T., Bernard, N., Guenther, S., Chen, C., Speleman, F., & Vandesompele, J. (2008). High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Research, 36(21), e143-e143. doi:10.1093/nar/gkn725 es_ES
dc.description.references Nolan, T., Hands, R. E., & Bustin, S. A. (2006). Quantification of mRNA using real-time RT-PCR. Nature Protocols, 1(3), 1559-1582. doi:10.1038/nprot.2006.236 es_ES
dc.description.references Zipper, H. (2004). Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Research, 32(12), e103-e103. doi:10.1093/nar/gnh101 es_ES
dc.description.references Mohammadian, A., Mowla, S. J., Elahi, E., Tavallaei, M., Nourani, M. R., & Liang, Y. (2013). Normalization of miRNA qPCR high-throughput data: a comparison of methods. Biotechnology Letters, 35(6), 843-851. doi:10.1007/s10529-013-1150-5 es_ES
dc.description.references Xie, Y., Todd, N. W., Liu, Z., Zhan, M., Fang, H., Peng, H., … Jiang, F. (2010). Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer, 67(2), 170-176. doi:10.1016/j.lungcan.2009.04.004 es_ES
dc.description.references Yu, S.-L., Chen, H.-Y., Chang, G.-C., Chen, C.-Y., Chen, H.-W., Singh, S., … Yang, P.-C. (2008). MicroRNA Signature Predicts Survival and Relapse in Lung Cancer. Cancer Cell, 13(1), 48-57. doi:10.1016/j.ccr.2007.12.008 es_ES
dc.description.references Mascaux, C., Laes, J. F., Anthoine, G., Haller, A., Ninane, V., Burny, A., & Sculier, J. P. (2008). Evolution of microRNA expression during human bronchial squamous carcinogenesis. European Respiratory Journal, 33(2), 352-359. doi:10.1183/09031936.00084108 es_ES
dc.description.references Silva, J., Garcia, V., Zaballos, A., Provencio, M., Lombardia, L., Almonacid, L., … Bonilla, F. (2010). Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. European Respiratory Journal, 37(3), 617-623. doi:10.1183/09031936.00029610 es_ES
dc.description.references Berghmans, T., Ameye, L., Willems, L., Paesmans, M., Mascaux, C., Lafitte, J. J., … Sculier, J. P. (2013). Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer, 82(2), 340-345. doi:10.1016/j.lungcan.2013.07.020 es_ES
dc.description.references Hennessey, P. T., Sanford, T., Choudhary, A., Mydlarz, W. W., Brown, D., Adai, A. T., … Califano, J. A. (2012). Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer. PLoS ONE, 7(2), e32307. doi:10.1371/journal.pone.0032307 es_ES
dc.description.references Skrzypski, M., Czapiewski, P., Goryca, K., Jassem, E., Wyrwicz, L., Pawłowski, R., … Jassem, J. (2014). Prognostic value of microRNA expression in operable non-small cell lung cancer patients. British Journal of Cancer, 110(4), 991-1000. doi:10.1038/bjc.2013.786 es_ES
dc.description.references Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., & Pass, H. I. (2013). microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer. Journal of Thoracic Oncology, 8(9), 1156-1162. doi:10.1097/jto.0b013e318299ac32 es_ES
dc.description.references Rosenfeld, N., Aharonov, R., Meiri, E., Rosenwald, S., Spector, Y., Zepeniuk, M., … Barshack, I. (2008). MicroRNAs accurately identify cancer tissue origin. Nature Biotechnology, 26(4), 462-469. doi:10.1038/nbt1392 es_ES
dc.description.references Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., … Sozzi, G. (2011). MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proceedings of the National Academy of Sciences, 108(9), 3713-3718. doi:10.1073/pnas.1100048108 es_ES
dc.description.references Yu, L., Todd, N. W., Xing, L., Xie, Y., Zhang, H., Liu, Z., … Jiang, F. (2010). Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. International Journal of Cancer, 127(12), 2870-2878. doi:10.1002/ijc.25289 es_ES
dc.description.references Xing, L., Todd, N. W., Yu, L., Fang, H., & Jiang, F. (2010). Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Modern Pathology, 23(8), 1157-1164. doi:10.1038/modpathol.2010.111 es_ES
dc.description.references Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., … Jiang, F. (2010). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory Investigation, 91(4), 579-587. doi:10.1038/labinvest.2010.194 es_ES
dc.description.references Campayo, M., Navarro, A., Viñolas, N., Diaz, T., Tejero, R., Gimferrer, J. M., … Marrades, R. (2012). Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. European Respiratory Journal, 41(5), 1172-1178. doi:10.1183/09031936.00048712 es_ES
dc.description.references Zhu, W., Liu, X., He, J., Chen, D., Hunag, Y., & Zhang, Y. K. (2011). Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study. BMC Cancer, 11(1). doi:10.1186/1471-2407-11-393 es_ES
dc.description.references Duncavage, E., Goodgame, B., Sezhiyan, A., Govindan, R., & Pfeifer, J. (2010). Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non-small Cell Lung Cancer. Journal of Thoracic Oncology, 5(11), 1755-1763. doi:10.1097/jto.0b013e3181f3909d es_ES
dc.description.references Chen, Q., Si, Q., Xiao, S., Xie, Q., Lin, J., Wang, C., … Wang, L. (2012). Prognostic significance of serum miR-17-5p in lung cancer. Medical Oncology, 30(1). doi:10.1007/s12032-012-0353-2 es_ES
dc.description.references Zhang, H., Su, Y., Xu, F., Kong, J., Yu, H., & Qian, B. (2013). Circulating MicroRNAs in Relation to EGFR Status and Survival of Lung Adenocarcinoma in Female Non-Smokers. PLoS ONE, 8(11), e81408. doi:10.1371/journal.pone.0081408 es_ES
dc.description.references Garofalo, M., Romano, G., Di Leva, G., Nuovo, G., Jeon, Y.-J., Ngankeu, A., … Croce, C. M. (2011). EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine, 18(1), 74-82. doi:10.1038/nm.2577 es_ES
dc.description.references Romano, G., Acunzo, M., Garofalo, M., Di Leva, G., Cascione, L., Zanca, C., … Croce, C. M. (2012). MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proceedings of the National Academy of Sciences, 109(41), 16570-16575. doi:10.1073/pnas.1207917109 es_ES
dc.description.references Kreil, D. P., Russell, R. R., & Russell, S. (2006). [4] Microarray Oligonucleotide Probes. DNA Microarrays, Part A: Array Platforms and Wet-Bench Protocols, 73-98. doi:10.1016/s0076-6879(06)10004-x es_ES
dc.description.references KRICHEVSKY, A. M. (2003). A microRNA array reveals extensive regulation of microRNAs during brain development. RNA, 9(10), 1274-1281. doi:10.1261/rna.5980303 es_ES
dc.description.references SHINGARA, J. (2005). An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA, 11(9), 1461-1470. doi:10.1261/rna.2610405 es_ES
dc.description.references Castoldi, M. (2006). A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA, 12(5), 913-920. doi:10.1261/rna.2332406 es_ES
dc.description.references Wang, H., Ach, R. A., & Curry, B. (2006). Direct and sensitive miRNA profiling from low-input total RNA. RNA, 13(1), 151-159. doi:10.1261/rna.234507 es_ES
dc.description.references Davison, T. S., Johnson, C. D., & Andruss, B. F. (2006). [2] Analyzing Micro‐RNA Expression Using Microarrays. DNA Microarrays, Part B: Databases and Statistics, 14-34. doi:10.1016/s0076-6879(06)11002-2 es_ES
dc.description.references Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., … Croce, C. M. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences, 103(7), 2257-2261. doi:10.1073/pnas.0510565103 es_ES
dc.description.references Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., … Harris, C. C. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9(3), 189-198. doi:10.1016/j.ccr.2006.01.025 es_ES
dc.description.references Patnaik, S. K., Kannisto, E., Knudsen, S., & Yendamuri, S. (2009). Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer after Surgical Resection. Cancer Research, 70(1), 36-45. doi:10.1158/0008-5472.can-09-3153 es_ES
dc.description.references Patnaik, S. K., Yendamuri, S., Kannisto, E., Kucharczuk, J. C., Singhal, S., & Vachani, A. (2012). MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma. PLoS ONE, 7(9), e46045. doi:10.1371/journal.pone.0046045 es_ES
dc.description.references Roth, C., Stückrath, I., Pantel, K., Izbicki, J. R., Tachezy, M., & Schwarzenbach, H. (2012). Low Levels of Cell-Free Circulating miR-361-3p and miR-625* as Blood-Based Markers for Discriminating Malignant from Benign Lung Tumors. PLoS ONE, 7(6), e38248. doi:10.1371/journal.pone.0038248 es_ES
dc.description.references Metzker, M. L. (2009). Sequencing technologies — the next generation. Nature Reviews Genetics, 11(1), 31-46. doi:10.1038/nrg2626 es_ES
dc.description.references Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., … Chen, Z. (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437(7057), 376-380. doi:10.1038/nature03959 es_ES
dc.description.references Pritchard, C. C., Cheng, H. H., & Tewari, M. (2012). MicroRNA profiling: approaches and considerations. Nature Reviews Genetics, 13(5), 358-369. doi:10.1038/nrg3198 es_ES
dc.description.references Beane, J., Vick, J., Schembri, F., Anderlind, C., Gower, A., Campbell, J., … Spira, A. (2011). Characterizing the Impact of Smoking and Lung Cancer on the Airway Transcriptome Using RNA-Seq. Cancer Prevention Research, 4(6), 803-817. doi:10.1158/1940-6207.capr-11-0212 es_ES
dc.description.references Kalari, K. R., Rossell, D., Necela, B. M., Asmann, Y. W., Nair, A., Baheti, S., … Thompson, E. A. (2012). Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations. Frontiers in Oncology, 2. doi:10.3389/fonc.2012.00012 es_ES
dc.description.references Ju, Y. S., Lee, W.-C., Shin, J.-Y., Lee, S., Bleazard, T., Won, J.-K., … Seo, J.-S. (2011). A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Research, 22(3), 436-445. doi:10.1101/gr.133645.111 es_ES
dc.description.references Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., … Zhang, C.-Y. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research, 18(10), 997-1006. doi:10.1038/cr.2008.282 es_ES
dc.description.references Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., … Shen, H. (2010). Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer. Journal of Clinical Oncology, 28(10), 1721-1726. doi:10.1200/jco.2009.24.9342 es_ES
dc.description.references Keller, A., Backes, C., Leidinger, P., Kefer, N., Boisguerin, V., Barbacioru, C., … Meese, E. (2011). Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Molecular BioSystems, 7(12), 3187. doi:10.1039/c1mb05353a es_ES
dc.description.references Meng, W., Ye, Z., Cui, R., Perry, J., Dedousi-Huebner, V., Huebner, A., … Lautenschlaeger, T. (2013). MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma. Clinical Cancer Research, 19(19), 5423-5433. doi:10.1158/1078-0432.ccr-13-0320 es_ES
dc.description.references Nuovo, G. J. (2010). In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets. Methods, 52(4), 307-315. doi:10.1016/j.ymeth.2010.08.009 es_ES
dc.description.references Jørgensen, S., Baker, A., Møller, S., & Nielsen, B. S. (2010). Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods, 52(4), 375-381. doi:10.1016/j.ymeth.2010.07.002 es_ES
dc.description.references Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., … Olson, E. N. (2008). The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis. Developmental Cell, 15(2), 261-271. doi:10.1016/j.devcel.2008.07.002 es_ES
dc.description.references Voortman, J., Goto, A., Mendiboure, J., Sohn, J. J., Schetter, A. J., Saito, M., … Giaccone, G. (2010). MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma. Cancer Research, 70(21), 8288-8298. doi:10.1158/0008-5472.can-10-1348 es_ES
dc.description.references Nuovo, G. J. (2008). In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods, 44(1), 39-46. doi:10.1016/j.ymeth.2007.10.008 es_ES
dc.description.references Donnem, T., Lonvik, K., Eklo, K., Berg, T., Sorbye, S. W., Al-Shibli, K., … Busund, L.-T. (2011). Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer. Cancer, 117(14), 3193-3200. doi:10.1002/cncr.25907 es_ES
dc.description.references Donnem, T., Eklo, K., Berg, T., Sorbye, S. W., Lonvik, K., Al-Saad, S., … Busund, L.-T. (2011). Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization. Journal of Translational Medicine, 9(1). doi:10.1186/1479-5876-9-6 es_ES
dc.description.references Donnem, T., Fenton, C. G., Lonvik, K., Berg, T., Eklo, K., Andersen, S., … Busund, L.-T. (2012). MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer. PLoS ONE, 7(1), e29671. doi:10.1371/journal.pone.0029671 es_ES
dc.description.references Eilertsen, M., Andersen, S., Al-Saad, S., Richardsen, E., Stenvold, H., Hald, S. M., … Bremnes, R. M. (2014). Positive prognostic impact of miR-210 in non-small cell lung cancer. Lung Cancer, 83(2), 272-278. doi:10.1016/j.lungcan.2013.11.005 es_ES
dc.description.references He, L., & Hannon, G. J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics, 5(7), 522-531. doi:10.1038/nrg1379 es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem